Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Control of Metastases via Myeloid CD39 and NK Cell Effector Function.

Yan J, Li XY, Roman Aguilera A, Xiao C, Jacoberger-Foissac C, Nowlan B, Robson SC, Beers C, Moesta AK, Geetha N, Teng MWL, Smyth MJ.

Cancer Immunol Res. 2020 Jan 28. doi: 10.1158/2326-6066.CIR-19-0749. [Epub ahead of print]

PMID:
31992567
2.

Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity.

Dougall WC, Roman Aguilera A, Smyth MJ.

Clin Transl Immunology. 2019 Sep 27;8(10):e01081. doi: 10.1002/cti2.1081. eCollection 2019.

3.

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity.

Roman Aguilera A, Lutzky VP, Mittal D, Li XY, Stannard K, Takeda K, Bernhardt G, Teng MWL, Dougall WC, Smyth MJ.

Oncoimmunology. 2018 Feb 1;7(5):e1424677. doi: 10.1080/2162402X.2018.1424677. eCollection 2018.

Supplemental Content

Loading ...
Support Center